BioNTech SE
- BNTX
- NASDAQ
- Biotechnology
- mRNA Vaccines/Therapeutics
- Cancer Immunotherapy
$87.71
Today −2.76%Quote Oct 16, 2026, 08:00 PM UTC
−11.10%over the last month
Max drawdown −13.0%From 1-month high −13.0%3 months −4.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$21.64B
Quote Oct 16
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$120.33
+37.2% from here
Floor
$85.46
2.6% below price
Where the price sits
24 analysts
Analyst range, low to high
$96.00$140.00
- Price $87.71
- Resistance $87.57–$88.45
- Consensus $120.33
Analysts' average target sits about 37% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BNTXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
7,807